The phenotypes and their prognosis of oral verrucous carcinoma
The phenotypes and their prognosis of oral verrucous carcinoma
出处
《中国口腔颌面外科杂志》
CAS
2008年第B05期105-105,共1页
China Journal of Oral and Maxillofacial Surgery
-
1胡志勇,崔延军.口腔疣状癌临床病理观察[J].口腔医学研究,2010,26(5):770-771.
-
2YUAN Shu-Lan,HUANG Ren-Min,WANG Xiu-Jie,SONG Yi,HUANG Guang-Qi.Reversing effect of Tanshinone on malignant phenotypes of human hepatocarcinoma cell line[J].World Journal of Gastroenterology,1998,4(4):45-47. 被引量：9
-
3唐瞻贵,王月红.口腔疣状癌研究进展[J].中华口腔医学研究杂志（电子版）,2010,4(5):1-5. 被引量：11
-
4Xia Zhang,Tetsuya Tsukamoto,Tsutomu Mizoshita,Ban Hisayo,Toyoda Takeshi,Masae Tatematsu.Expression of Osteopontin and caudal-related homeobox gene 2:indications of phenotypes and prognosis in advanced gastric cancer[J].福州总医院学报,2010,17(4):212-217. 被引量：1
-
5Fumiaki Toki,Atsushi Takahashi,Ryusuke Aihara,Kyoichi Ogata,Hiroyuki Ando,Tetsuro Ohno,Erito Mochiki,Hiroyuki Kuwano.Relationship between clinicopathological features and mucin phenotypes of advanced gastric adenocarcinoma[J].World Journal of Gastroenterology,2010,16(22):2764-2770. 被引量：2
-
6Qingyi Wei.DNA repair genotypes and phenotypes and cancer susceptibility[J].Journal of Nanjing Medical University,2008,22(1):46-46.
-
7关钧,范慕贞,曹淑兰.REVERSION OF MALIGNANT PHENOTYPES OF HUMAN LUNG SQUAMOUS CARCINOMA CELLS BY ORNITHINE DECARBOXYLASE ANTISENSE RNA[J].Chinese Journal of Cancer Research,1996,8(4):240-243. 被引量：4
-
8Albert J Czaja,Yusuf Bayraktar.Non-classical phenotypes of autoimmune hepatitis and advances in diagnosis and treatment[J].World Journal of Gastroenterology,2009,15(19):2314-2328. 被引量：4
-
9Sotiris Lakis,Theodora Papamitsou,Constantina Panagiotopoulou,Rodoula Kotakidou,Vassiliki Kotoula.AMACR is associated with advanced pathologic risk factors in sporadic colorectal adenomas[J].World Journal of Gastroenterology,2010,16(20):2476-2483. 被引量：1
-
10MingShi BingZhang Zi-RongTang Zhou-YunLei Hui-FenWang Yong-YiFeng Zhen-PingFan Dong-PingXu Fu-ShengWang.Autologous cytokine-induced killer cell therapy in clinical trial phase I is safe in patients with primary hepatocellular carcinoma[J].World Journal of Gastroenterology,2004,10(8):1146-1151. 被引量：97
